Skip to main content

Cancer Immunology, Immunotherapy

Ausgabe 3/2001

Inhalt (7 Artikel)

ORIGINAL ARTICLE

High-scale expansion of melanoma-reactive TIL by a polyclonal stimulus: predictability and relation with disease advancement

Marie-Christine Pandolfino, Nathalie Labarrière, Marie-Hélène Tessier, Alain Cassidanius, Sylvain Bercegeay, Philippe Lemarre, Frédéric Dehaut, Brigitte Dréno, Francine Jotereau

ORIGINAL ARTICLE

Gamma /delta T cells provide innate immunity against renal cell carcinoma

Hirohito Kobayashi, Yoshimasa Tanaka, Junji Yagi, Hiroshi Toma, Takehiko Uchiyama

ORIGINAL ARTICLE

The anti-tumor activity of anti-CTLA-4 is mediated through its induction of IFNγ

Timothy J. Paradis, Eugenia Floyd, Jeff Burkwit, Susan H. Cole, Brandon Brunson, Eileen Elliott, Steven Gilman, Ronald P. Gladue

ORIGINAL ARTICLE

Tumor cell killing by in vitro affinity-matured recombinant human monoclonal antibodies

Gerwin Huls, David Gestel, Joke van der Linden, Ed Moret, Ton Logtenberg

ORIGINAL ARTICLE

Lymphocyte subsets and viral load in patients with HIV-associated non-Hodgkin's lymphoma treated with anti-CD20 monoclonal antibody and chemotherapy

P. De Paoli, E. Vaccher, R. Tedeschi, C. Caffau, S. Zanussi, M. T. Bortolin, C. Crepaldi, M. Spina, U. Tirelli

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.